Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Clinical research study
Current Issue
Editorial Board
Literature Review
Narrative review
Original Article
Research Article
Review Article
Short Report
Surgical techniques
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Clinical research study
Current Issue
Editorial Board
Literature Review
Narrative review
Original Article
Research Article
Review Article
Short Report
Surgical techniques
View/Download PDF

Translate this page into:

50 (); 162-169
doi:
10.1016/j.jor.2023.12.010

Treatment of 2-part, 3-part, and 4-part proximal humerus fractures from 2016 to 2020: A nationally-representative database

LifeBridge Health, Sinai Hospital of Baltimore, Rubin Institute for Advanced Orthopedics, Baltimore, MD, USA

∗Corresponding author: John V. Ingari. ingari.hand@gmail.com

Disclaimer:
This article was originally published by Reed Elsevier India Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Abstract

Complex proximal humerus fractures pose challenges in elderly patients, as this common scenario can lead to unpredictable outcomes, regardless of treatment method. Given the evolving nature of the treatment for 3-and-4-part proximal humerus fractures, an epidemiological analysis offers a way to minimize the gap between appropriate understanding and effective intervention. As such, we aimed to i) evaluate the trends of nonoperative and operative management; and ii) compare the complication rates of ORIF to conversion ORIF (to RTSA).

We utilized a national, all-payer database to include patients who underwent open reduction and internal fixation for 2-part (n = 2783), 3-part (n = 2170), 4-part (n = 1087) proximal humerus fractures between April 2016 to December 2022. Patients who failed ORIF to RTSA included n = 108 for 2-part fractures, n = 123 for 3-part fractures, and n = 128 for 4-part fractures. We collected demographic and postoperative medical and surgical complications at 90-days, in addition to time-interval between ORIF and RTSA.

The malunion and nonunion rates for ORIF between different types of proximal humerus fractures were similar (2-part fractures: 1.8 %, 4.7 %; 3-part fractures: 1.8 %, 3.5 %; 4-part fractures: 2.4 %, 3.7 %). The conversion rates of failed ORIF to RTSA were 1.9 %, 2.8 %, and 5.9 % for 2-part, 3-part, and 4-part fractures, respectively. The time interval from failed ORIF to RTSA was 190 days for 2-part fractures, 169 days for 3-part fractures, and 129 for 4-part fractures.

An epidemiological analysis of proximal humerus fractures by fracture type demonstrated an increase in RTSA for 2-part, 3-part, and 4-part fractures while nonoperative treatment showed no change from 2016 to 2020. Additional research is needed to determine which fractures are best treated operatively while maximizing outcomes. In the setting of complex proximal humerus fractures, several options seem feasible depending on patient demographic characteristics.

1

1 Introduction

Proximal humerus fractures, accounting for 4 %–5 % of all fractures, have shown a consistent annual increase of over 13 % in the last three decades.1–3 Managing these fractures optimally is challenging due to the complexities of preserving bone alignment, joint surface congruity, and humeral head vascularity.4 Decision-making for operative treatment involves considering various factors such as age, activity level, patient expectations, medical comorbidities, bone quality, degree of comminution, previous surgeries, associated injuries, and fracture type.5 While nonoperative treatment is common for most proximal humerus fractures, there is no consensus on the preferred strategy for 3-part and 4-part fractures.

Historically, open reduction and internal fixation (ORIF) were employed in young patients to preserve bone stock and promote anatomic healing for 3-and 4-part proximal humerus fractures.6 However, ORIF has been associated with complication and reoperation rates as high as 35 %,7 leading to issues like pain, disability, osteonecrosis, malunion, nonunion, post-traumatic arthritis, and humeral head collapse.8 Hemiarthroplasty (HA) outcomes have also been inconsistent, with poor functional results.9–11 Reverse total shoulder arthroplasty (RTSA) has emerged as an attractive alternative for low-demand and elderly patients, offering more consistent outcomes, faster recovery, reduced postoperative rehabilitation, and less reliance on tuberosity healing.12,13

An epidemiological analysis spanning from 2008 to 2017 revealed a significant increase in nonoperative management from 67.6 % to 77.2 % (P = 0.001), a decrease in ORIF use from 76.6 % to 72.6 % (P = 0.004), a significant rise in RTSA utilization from 4.1 % to 24.5 % (P < 0.001), and a notable decrease in HA use from 19.3 % to 3 % (P < 0.001).14 However, studies comparing RTSA use in the acute setting versus post-failed ORIF are limited due to small sample sizes, single institution analyses, and the absence of fracture type (2-part, 3-part, and 4-part) distinction.15–17 Given the evolving landscape of treatment for 3-and-4-part proximal humerus fractures, an epidemiological analysis provides a means to bridge the gap between understanding and effective intervention. Thus, our objectives were to i) assess the trends in nonoperative and operative management, and ii) compare complication rates between ORIF and conversion ORIF (to RTSA).

2

2 Methods

We conducted a review of Medicare inpatient and outpatient facility data using the Pearldiver, an all-payer national database based in Warsaw, IN, USA. Pearldiver is a Health Insurance Portability and Accountability Act (HIPAA)-compliant database that encompasses Medicare data spanning from 2005 to 2022. It allows access to Medicare files through Current Procedural Terminology (CPT) codes from the American Medical Association, Chicago, IL, USA, and International Classification of Disease Tenth Edition (ICD-10) codes. To maintain patient privacy, the database does not report groups with 10 patients or fewer.

Included in our study were patients who underwent open reduction and internal fixation (ORIF) for 2-part (n = 2783), 3-part (n = 2170), and 4-part (n = 1087) proximal humerus fractures from April 2016 to December 2021. During the same timeframe, we also considered patients who experienced failed ORIF and subsequently underwent reverse total shoulder arthroplasty (RTSA), including n = 108 for 2-part fractures, n = 123 for 3-part fractures, and n = 128 for 4-part fractures. We collected demographic information and postoperative medical and surgical complications within a 90-day period, along with the time interval between ORIF and RTSA. The Neer classification, which divides proximal humerus fractures into four parts (humeral head, greater tuberosity, less tuberosity, and humeral shaft), guided our classification.

Our statistical analyses primarily employed descriptive methods to capture the incidence of each procedure from 2016 to 2020. Significance was determined at a p-value <0.05, and chi-squared tests were used to compare complication rates. All statistical analyses were performed using SPSS 29 software from IBM Corp, Armonk, NY, USA.

3

3 Results

During the 5-year study period examined, a total of 17,760 patients who had proximal humerus fractures were treated nonoperatively (Table 1). A total of 19,157, 1,263, and 5209 patients who had proximal humerus fractures were treated with ORIF, HA, and RTSA, respectively in the Medicare population (Tables 2–4). In 2016, 2938 patients had proximal humerus fractures treated nonoperatively (Fig. 1). In 2016, 3,465, 342, and 724 patients who had proximal humerus fractures were treated with ORIF, HA, and RTSA, respectively. In 2020, 2756 patients had proximal humerus fractures treated nonoperatively. In 2020, 3,265,207, and 1464 patients who had proximal humerus fractures were treated with ORIF, HA, and RTSA, respectively (Figs. 1–4). Demographics and baseline characteristics for nonoperative treatment, ORIF, HA, and RTSA are detailed in Tables 1–4 Complications for nonoperative treatment, ORIF, HA, and RTSA are detailed in Tables 5–8.

Table 1 Demographics and Baseline characteristics for Nonoperative Management.
2-Part 3-Part 4-Part Greater Tuberosity Surgical Neck p-value
n = 1586 (%) n = 724 (%) n = 228 (%) n = 5255 (%) n = 9967 (%)
Age (SD) <0.001
<40 136 (8.1) NA NA 447 (8.5) 696 (7.0)
40 to 44 17 (1.0) NA NA 153 (2.9) 105 (1.1)
45 to 49 22 (1.3) 17 (2.2) 16 (6.6) 231 (4.4) 173 (1.7)
50 to 54 82 (4.9) 22 (2.9) 12 (4.9) 416 (7.9) 432 (4.3)
55 to 59 152 (9.1) 64 (8.3) 20 (8.2) 593 (11.3) 728 (7.3)
60 to 64 157 (9.4) 93 (12.1) 27 (11.1) 785 (14.9) 1081 (10.8)
65 to 69 181 (10.8) 99 (12.9) 30 (12.3) 611 (11.6) 1158 (11.6)
70 to 74 187 (11.2) 129 (16.8) 31 (12.7) 640 (12.2) 1292 (13.0)
75 to 79 387 (23.1) 178 (23.1) 67 (27.5) 837 (15.9) 2448 (24.6)
80 to 84 341 (20.4) 140 (18.2) 45 (18.4) 615 (11.7) 2036 (20.4)
Sex 0.005
Female 1222 (77.0) 604 (83.4) 186 (81.6) 4093 (77.9) 7788 (78.1)
Male 364 (23.0) 120 (16.6) 42 (18.4) 1162 (22.1) 2179 (21.9)
Alcohol Abuse 192 (12.1) 65 (9.0) 35 (15.4) 800 (15.2) 1253 (12.6) <0.001
CCI >3 416 (26.2) 151 (20.9) 53 (23.2) 1211 (23.0) 3047 (30.6) <0.001
Congestive Heart Failure 191 (12.0) 91 (12.6) 30 (13.2) 509 (9.7) 1305 (13.1) <0.001
Chronic Kidney Disease 425 (26.8) 199 (27.5) 72 (31.6) 1181 (22.5) 2998 (30.1) <0.001
Depression 748 (47.2) 323 (44.6) 110 (48.2) 2718 (51.7) 5068 (50.8) <0.001
DM 702 (44.3) 341 (47.1) 99 (43.4) 2319 (44.1) 4722 (47.4) <0.001
Hypertension 1241 (78.2) 609 (84.1) 190 (83.3) 4028 (76.7) 8141 (81.7) <0.001
Hypothyroidism 504 (31.8) 272 (37.6) 88 (38.6) 1728 (32.9) 3447 (34.6) 0.007
Rheumatoid Arthritis 85 (5.4) 27 (3.7) 15 (6.6) 260 (4.9) 469 (4.7) 0.299
Obesity 468 (29.5) 255 (35.2) 81 (35.5) 2009 (38.2) 3244 (32.5) <0.001
Tobacco Use 631 (39.8) 283 (39.1) 92 (40.4) 2475 (47.1) 4284 (43.0) <0.001
Table 2 Demographics and baseline characteristics for open reduction internal fixation (ORIF).
2-Part 3-Part 4-Part Greater Tuberosity Surgical Neck p-value
n = 2783 (%) n = 2170 (%) n = 1087 (%) n = 7645 (%) n = 5472 (%)
Age <0.001
<40 196 (6.9) 87 (3.9) 53 (4.9) 726 (9.5) 583 (10.7)
40 to 44 66 (2.3) 47 (2.1) 29 (2.7) 253 (3.3) 200 (3.7)
45 to 49 104 (3.7) 96 (4.3) 52 (4.8) 376 (4.9) 331 (6.0)
50 to 54 203 (7.2) 160 (7.2) 98 (9.0) 503 (6.6) 602 (11.0)
55 to 59 346 (12.2) 295 (13.3) 157 (14.4) 751 (9.8) 1000(18.3)
60 to 64 414 (14.6) 377 (17.0) 176 (16.2) 853 (11.2) 1230 (22.5)
65 to 69 407 (14.4) 357 (16.1) 193 (17.8) 741 (9.7) 1171 (21.4)
70 to 74 364 (12.9) 337 (15.2) 139 (12.8) 615 (8.0) 905 (16.5)
75 to 79 474 (16.8) 315 (14.2) 162 (14.9) 566 (7.4) 1198 (21.9)
80 to 84 238 (8.4) 113 (5.1) 65 (6.0) 163 (2.1) 549 (10.0)
Sex <0.001
Female 2127 (76.4) 1705 (78.6) 807 (73.6) 3677 (67.2) 5702 (74.6)
Male 656 (23.6) 465 (21.4) 290 (26.4) 1795 (32.8) 1943 (25.4)
Alcohol Abuse 516 (18.5) 303 (14.0) 174 (15.9) 970 (17.7) 1510 (19.8) <0.001
ECI >3 484 (17.4) 285 (13.1) 129 (11.8) 678 (12.4) 1484 (19.4) <0.001
Congestive Heart Failure 215 (7.7) 132 (6.1) 57 (5.2) 276 (5.0) 570 (7.5) <0.001
Chronic Kidney Disease 568 (20.4) 380 (17.5) 201 (18.3) 818 (14.9) 1611 (21.1) <0.001
Depression 1382 (49.7) 1016 (46.8) 486 (44.3) 2665 (48.7) 4038 (52.8) <0.001
DM 1119 (40.2) 879 (40.5) 429 (39.1) 1899 (34.7) 3074 (40.2) <0.001
Hypertension 2095 (75.3) 1631 (75.2) 847 (77.2) 3837 (70.1) 5784 (75.7) <0.001
Hypothyroidism 839 (30.1) 700 (32.3) 338 (30.8) 1449 (26.5) 2225 (29.1) <0.001
Rheumatoid Arthritis 122 (4.4) 112 (5.2) 40 (3.6) 198 (3.6) 314 (4.1) <0.001
Obesity 867 (31.2) 851 (39.2) 427 (38.9) 2246 (41.0) 2719 (35.6) <0.001
Tobacco Use 1291 (46.4) 913 (42.1) 452 (41.2) 2611 (47.7) 3787 (49.5) <0.001
Table 3 Demographics and baseline characteristics for reverse shoulder arthroplasty (RSA).
2-Part 3-Part 4-Part Greater Tuberosity Surgical Neck p-value
n = 487 (%) n = 553 (%) n = 840 (%) n = 1033 (%) n = 2306 (%)
Age
50 to 54 14 (2.4) 19 (2.9) 30 (3.2) 43 (4.2) 15 (0.7) <0.001
55 to 59 45 (7.6) 36 (5.6) 52 (5.6) 80 (7.7) 70 (3.0)
60 to 64 74 (12.6) 77 (11.9) 130 (13.9) 170 (16.5) 174 (7.5)
65 to 69 104 (17.7) 117 (18.1) 166 (17.8) 243 (23.5) 333 (14.4)
70 to 74 114 (19.4) 144 (22.3) 171 (18.3) 269 (26.0) 432 (18.7)
75 to 79 135 (22.9) 153 (23.7) 230 (24.6) 299 (28.9) 525 (22.8)
80 to 84 108 (18.3) 100 (15.5) 138 (14.8) 187 (18.1) 501 (31.2)
Sex 0.668
Female 389 (79.9) 451 (81.6) 694 (82.6) 845 (81.8) 1905 (82.6)
Male 98 (20.1) 102 (18.4) 146 (17.4) 188 (18.2) 401 (17.4)
Alcohol Abuse 74 (15.2) 72 (13.0) 110 (13.1) 127 (12.3) 336 (14.6) 0.336
CCI >3 117 (24.0) 123 (22.2) 186 (22.1) 226 (21.9) 626 (27.1) 0.250
Congestive Heart Failure 54 (11.1) 60 (10.8) 73 (8.7) 108 (10.5) 276 (12.0) 0.129
Chronic Kidney Disease 170 (34.9) 175 (31.6) 229 (27.3) 301 (29.1) 730 (31.7) 0.025
Depression 282 (57.9) 297 (53.7) 423 (50.4) 559 (54.1) 1256 (54.5) 0.103
DM 247 (50.7) 286 (51.7) 439 (52.3) 542 (52.5) 1142 (49.5) 0.471
Hypertension 444 (91.2) 512 (92.6) 761 (90.6) 935 (90.5) 2110 (91.5) 0.632
Hypothyroidism 181 (37.2) 230 (41.6) 336 (40.0) 392 (37.9) 892 (38.7) 0.530
Rheumatoid Arthritis 36 (7.4) 37 (6.7) 46 (5.5) 72 (7.0) 132 (5.7) 0.388
Obesity 212 (43.5) 272 (49.2) 414 (49.3) 490 (47.4) 1039 (45.1) 0.083
Tobacco Use 259 (53.2) 251 (45.4) 378 (45.0) 488 (47.2) 1151 (49.9) 0.011
Table 4 Demographics and baseline characteristics for hemiarthroplasty (HA).
2-Part 3-Part 4-Part Greater tuberosity Surgical Neck p-value
n = 127(%) n = 154(%) n = 245(%) n = 233 (%) n = 504 (%)
Age 0.135
45 to 49 NA NA 13 (5.2) 12 (5.2) 29 (5.8)
50 to 54 12 (9.3) NA 18 (7.3) 30 (12.9) 34 (6.7)
55 to 59 17 (13.2) 22 (12.6) 37 (14.9) 31 (13.3) 76 (15.1)
60 to 64 29 (22.5) 31 (17.7) 48 (19.4) 58 (24.9) 115 (22.8)
65 to 69 18 (14.0) 33 (18.9) 38 (15.3) 53 (22.7) 87 (17.3)
70 to 74 14 (10.9) 20 (11.4) 23 (9.3) 25 (10.7) 60 (11.9)
75 to 79 31 (24.0) 27 (15.4) 53 (21.4) 41 (17.6) 135 (26.8)
80 to 84 11 (8.5) 18 (10.3) 22 (8.9) NA 40 (7.9)
Sex 0.766
Female 87 (68.5) 103 (66.9) 174 (71.0) 163 (70.0) 363 (72.0)
Male 40 (31.5) 51 (33.1) 71 (29.0) 70 (30.0) 141 (28.0)
Alcohol Abuse 27 (21.3) 25 (16.2) 45 (18.4) 51 (21.9) 112 (22.2) 0.459
CCI >3 38 (29.9) 38 (24.7) 60 (24.5) 56 (22.9) 126 (25.0) 0.697
Congestive Heart Failure 13 (10.2) 17 (11.0) 22 (9.0) 20 (8.6) 61 (12.1) 0.568
Chronic Kidney Disease 47 (37.0) 46 (29.9) 69 (28.2) 54 (23.2) 133 (26.4) 0.069
Depression 78 (61.4) 86 (55.8) 126 (51.4) 126 (54.1) 284 (56.3) 0.436
DM 68 (53.5) 74 (48.1) 116 (47.3) 101 (43.3) 257 (51.0) 0.275
Hypertension 113 (89.0) 131 (85.1) 217 (88.6) 187 (80.3) 439 (87.1) 0.054
Hypothyroidism 38 (29.9) 59 (38.3) 87 (35.5) 81 (34.8) 180 (35.7) 0.682
Rheumatoid Arthritis *(*) 11 (7.1) 11 (4.5) 15 (6.4) 29 (5.8) 0.781
Obesity 52 (40.9) 66 (42.9) 109 (44.5) 106 (45.5) 228 (45.2) 0.907
Tobacco Use 66 (52.0) 82 (53.2) 114 (46.5) 113 (48.5) 266 (52.8) 0.477
Trends of treatment of 2-part proximal humerus fractures.
Fig. 1 Trends of treatment of 2-part proximal humerus fractures.
Trends of treatment of 3-part proximal humerus fractures.
Fig. 2 Trends of treatment of 3-part proximal humerus fractures.
Trends of treatment of greater tuberosity proximal humerus fractures.
Fig. 3 Trends of treatment of greater tuberosity proximal humerus fractures.
Trends of treatment of surgical neck proximal humerus fractures.
Fig. 4 Trends of treatment of surgical neck proximal humerus fractures.
Table 5 Bivariate analysis of complications in non-operative management.
2-Part 3-Part 4-Part Greater tuberosity Surgical Neck p-value
n = 1586 (%) n = 724 (%) n = 228 (%) n = 5255 (%) n = 9967 (%)
Malunion 26 (1.6) 22 (3.0) 13 (5.7) 52 (1.0) 169 (1.7) <0.001
Nonunion 32 (2.0) 11 (1.5) 12 (5.3) 46 (0.9) 216 (2.2) <0.001
Table 6 Bivariate analysis of complications in reverse shoulder arthroplasty.
2-Part 3-Part 4-Part Greater Tuberosity Surgical Neck p-value
n = 487 (%) n = 553 (%) n = 840 (%) n = 1033 (%) n = 2306 (%)
90-day Complications RSA
Aseptic Revision 16 (3.3) 18 (3.3) 33 (3.9) 46 (4.5) 68 (2.9) 0.239
Cardiac arrest a(a) a(a) a(a) a(a) 22 (1.0) 0.212
PE a(a) a(a) a(a) 0 (0.0) a(a) 0.720
PJI 15 (3.1) 11 (2.0) 14 (1.7) 21 (2.0) 35 (1.5) 0.207
Transfusion 52 (10.7) 36 (6.5) 66 (7.9) 58 (5.6) 200 (8.7) 0.003
SSI a(a) a(a) a(a) a(a) 17 (0.7) 0.654
WC a(a) 0 (0.0) a(a) a(a) 16 (0.7) 0.127
Conversion Revision 31 (6.4) 41 (7.4) 52 (6.2) 57 (5.5) 86 (3.7) 0.001
1-year Complications RSA
PJI 20 (4.1) 18 (3.3) 20 (2.4) 25 (2.4) 52 (2.3) 0.152
Aseptic Revision 23 (4.7) 22 (4.0) 38 (4.5) 52 (5.0) 82 (3.6) 0.308
Conversion Revision 20 (4.1) 23 (4.2) 30 (3.6) 41 (4.0) 51 (2.2) 0.013
SSI a(a) a(a) 15 (1.8) 16 (1.5) 34 (1.5) 0.739
2-year Complications RSA
PJI 25 (5.1) 20 (3.6) 23 (2.7) 31 (3.0) 67 (2.9) 0.108
Aseptic Revision 27 (5.5) 25 (4.5) 40 (4.8) 58 (5.6) 90 (3.9) 0.197
SSI 14 (2.9) a(a) 17 (2.0) 20 (1.9) 40 (1.7) 0.390
Censored in accordance with the database confidentiality agreement.
Table 7 Bivariate analysis of complications in hemiarthroplasty.
2-Part 3-Part 4-Part Greater Tuberosity Surgical Neck p-value
n = 127(%) n = 154(%) n = 245(%) n = 233 (%) n = 504 (%)
90-day Complications HA
Aseptic Revision a(a) a(a) 22 (9.0) 14 (6.0) 25 (5.0) 0.313
Cardiac arrest a(a) a(a) a(a) a(a) a(a) 0.885
PE 0 (0.0) 0 (0.0) 0 (0.0) a(a) a(a) 0.708
PJI a(a) a(a) 15 (6.1) a(a) 17 (3.4) 0.427
Transfusion 13 (10.2) 11 (7.1) 14 (5.7) 14 (6.0) 31 (6.2) 0.490
SSI a(a) a(a) a(a) a(a) 20 (4.0) 0.594
WC a(a) a(a) a(a) a(a) a(a) 0.740
Conversion Revision a(a) a(a) a(a) a(a) a(a) 0.172
1-year Complications HA
PJI a(a) a(a) 15 (6.1) a(a) 29 (5.8) 0.877
Aseptic Revision 12 (9.4) 12 (7.8) 26 (10.6) 15 (6.4) 33 (6.5) 0.298
Conversion Revision a(a) a(a) a(a) a(a) a(a) 0.119
SSI a(a) a(a) 12 (4.9) a(a) 31 (6.2) 0.315
2-year Complications HA
PJI a(a) 11 (7.1) 15 (6.1) 11 (4.7) 32 (6.3) 0.786
Aseptic Revision 14 (11.0) 14 (9.1) 30 (12.2) 17 (7.3) 40 (7.9) 0.264
SSI a(a) a(a) 12 (4.9) a(a) 38 (7.5) 0.074
Censored in accordance with the database confidentiality agreement.
Table 8 Bivariate analysis of complications in open reduction internal fixation.
2-Part 3-Part 4-Part Greater Tuberosity Surgical Neck p-value
n = 2783 (%) n = 2170 (%) n = 1087 (%) n = 7645 (%) n = 5472 (%)
Malunion 50 (1.8) 40 (1.8) 26 (2.4) 102 (1.9) 161 (2.1) 0.634
Nonunion 131 (4.7) 77 (3.5) 41 (3.7) 115 (2.1) 278 (3.6) <0.001
90-day Complications ORIF
Aseptic Revision 11 (0.4) a(a) a(a) 20 (0.4) 21 (0.3) 0.172
Cardiac arrest 14 (0.5) a(a) a(a) a(a) 30 (0.4) 0.092
PE a(a) a(a) 0 (0.0) a(a) a(a) 0.747
PJI 29 (1.0) 20 (0.9) 16 (1.5) 38 (0.7) 70 (0.9) 0.132
Transfusion 75 (2.7) 47 (2.2) 31 (2.8) 93 (1.7) 287 (3.8) <0.001
SSI 45 (1.6) 20 (0.9) 16 (1.5) 50 (0.9) 121 (1.6) 0.003
WC 19 (0.7) 12 (0.6) a(a) 40 (0.7) 61 (0.8) 0.732
Conversion Revision 40 (1.4) 49 (2.3) 61 (5.6) 80 (1.5) 120 (1.6) <0.001
1-year Complications ORIF
PJI 46 (1.7) 28 (1.3) 22 (2.0) 55 (1.0) 118 (1.5) 0.020
Aseptic Revision 16 (0.6) 14 (0.6) a(a) 26 (0.5) 45 (0.6) 0.507
Conversion Revision 68 (2.4) 74 (3.4) 67 (6.1) 117 (2.1) 156 (2.0) <0.001
SSI 60 (2.2) 29 (1.3) 19 (1.7) 69 (1.3) 168 (2.2) <0.001
2-year Complications ORIF
PJI 52 (1.9) 36 (1.7) 28 (2.6) 72 (1.3) 146 (1.9) 0.020
Aseptic Revision 16 (0.6) 17 (0.8) 15 (1.4) 34 (0.6) 57 (0.7) 0.087
SSI 67 (2.4) 34 (1.6) 20 (1.8) 79 (1.4) 196 (2.6) <0.001
Censored in accordance with the database confidentiality agreement.

The malunion and nonunion rates for ORIF between different types of proximal humerus fractures were similar (2-part fractures: 1.8 %, 4.7 %; 3-part fractures: 1.8 %, 3.5 %; 4-part fractures: 2.4 %, 3.7 %). The conversion rates of failed ORIF to RTSA were 1.9 %, 2.8 %, and 5.9 % for 2-part, 3-part, and 4-part fractures, respectively (Table 8). The time interval from failed ORIF to RTSA was 190 days for 2-part fractures, 169 days for 3-part fractures, and 129 for 4-part fractures (Table 9).

Table 9 Open reduction internal fixation to arthroplasty.
Days (SD) Overall 2-Part 3-Part 4-Part Greater Tuberosity Surgical Neck
RSA 562 (740.3) 190 (287.6) 169 (265.1) 129 (295.1) 171 (270.7) 172 (286.8)
TSA 517 (677.7) 212 (330.5) 176.9 (325.6) 98 (214.3) 189 (325.1) 159 (274.5)
4

4 Discussion

Despite the rising incidence of proximal humerus fractures in the elderly, a consensus on the optimal treatment strategy remains elusive.14 Furthermore, existing studies on US epidemiological trends related to proximal humerus fractures often lack emphasis on fracture types, relying on small sample sizes and single-institution analyses.15–17 Our key findings indicate: (1) RTSA experienced the most significant increase from 2016 to 2020, irrespective of fracture type; and (2) the conversion rates of failed ORIF to RTSA for 4-part fractures were twice as high as the malunion and nonunion rates of ORIF.

We acknowledge certain limitations in our study. Despite third-party review of all patient records, the possibility of medical billing and coding errors exists. The reported nationwide billing/coding error rate of 1.0 % by the United States Department of Human and Health Services further mitigates this risk.18 Exclusion of specific CPT codes for specificity may have led to an underestimation of the number of procedures. Additionally, the SARS-CoV-2 (COVID-19) pandemic might have influenced the number of procedures performed in a given year. Certain CPT codes amalgamate multiple procedures (e.g., HA, TSA, and RTSA), hindering the distinction between them. While our study focuses on the Medicare population representing the elderly in the United States, its applicability to other countries may be limited. Given the nature of our study, inferences can only be drawn based on the identified trends. Notably, our study boasts strengths such as a large sample size, the classification of fractures by type, and exclusive use of ICD-10 codes.

Several studies highlight an increasing rate of RTSA in the US for proximal humerus fractures. Patel et al. reported a 1841.4 % increase (P < 0.001) in RTSA from 2010 to 2019, attributed to high prosthesis survival, satisfactory functional outcomes, and greater tolerance for tuberosity positioning and healing compared to ORIF and HA.19–21 Hasty et al. found a 406 % increase in RTSA, a 47 % decrease in HA, and constant ORIF rates from 2005 to 2012, with an overall rise in operative vs. nonoperative management for all fractures.22 However, these studies did not delve into trends based on fracture type. Bahrs et al. found no significant increase (p = 0.09) in fracture severity from 2006 to 2011 but observed a higher occurrence of complex proximal humerus fractures in older women with comorbidities.23 Iglesias-Rodriguez et al. linked the increase in complex fractures to advancements in RTSA options and the preference for surgical interventions.24

Our study reveals high malunion and nonunion rates in 4-part fractures undergoing ORIF, prompting consideration of salvage ORIF to RTSA efficacy compared to acute RTSA. Studies show higher complication rates and worse outcomes in RSA after failed ORIF compared to acute RTSA, potentially due to better tuberosity repair in acute RTSA versus malpositioned union in late RTSA.25–27 Patient demographic characteristics influence RTSA outcomes, with older age, dependent functional status, and higher American Society of Anesthesiologists designation being factors. These factors, coupled with the acuity of proximal humerus fractures, may contribute to surgeons opting for RTSA in select patients.28–30 In contrast, ORIF remains a viable option with good functional outcomes in young patients.31

Nonoperative treatment for 2-part, 3-part, and 4-part fractures remained unchanged from 2016 to 2020, while RTSA increased during this period. A meta-analysis suggested an initial trial of nonoperative treatment in the elderly, reserving RTSA for cases where nonoperative treatment fails, potentially resulting in fewer patients ultimately requiring RTSA. Du et al. compared studies and found that RTSA had significantly higher Constant scores and lower reoperation rates than nonoperation, HA, and ORIF for 3-or 4-part proximal humeral fractures.32 Lopiz et al.'s prospective trial indicated less pain perception in RTSA patients, although functional outcomes were similar at 12 months postoperatively.33

Our epidemiological analysis of proximal humerus fractures by type revealed an increase in RTSA for 2-part, 3-part, and 4-part fractures, while nonoperative treatment showed no change from 2016 to 2020. Further research is needed to determine the most effective operative treatments while optimizing outcomes, especially in the context of complex proximal humerus fractures and varied patient demographic characteristics.

Funding

None.

Data availability

Available in a respository upon request.

Patient consent

No patient consent needed due to retrospective nature and public database.

Ethical approval

IRB exemption due to retrospective nature and public database.

Use of AI tool

No use of AI tool.

CRediT authorship contribution statement

Sandeep S. Bains: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Roles, Writing – original draft, and, Writing – review & editing. Jeremy A. Dubin: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Roles, Writing – original draft, and, Writing – review & editing. Ethan A. Remily: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Roles, Writing – original draft, and, Writing – review & editing. Ruby Gilmor: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Roles, Writing – original draft, and, Writing – review & editing. Daniel Hameed: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Roles, Writing – original draft, and, Writing – review & editing. Rubén Monárrez: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Roles, Writing – original draft, and, Writing – review & editing. John V. Ingari: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Roles, Writing – original draft, and, Writing – review & editing.

References

  1. , , , et al . Surgical management of complex proximal humerus fractures-a systematic review of 92 studies including 4500 patients. J Orthop Trauma. 2015 Jan;29(1):54-59.
    [Google Scholar]
  2. , , , . Epidemiology of humerus fractures in the United States: nationwide emergency department sample, 2008. Arthritis Care Res. 2012 Mar;64(3):407-414.
    [Google Scholar]
  3. , , , et al . Proximal humerus fractures - epidemiology, comparison of mortality rates after surgical versus non-surgical treatment, and analysis of risk factors based on Medicare registry data. Bone Joint Res. 2023 Feb;12(2):103-112.
    [Google Scholar]
  4. , , , . Complex proximal humeral fractures in adults--a systematic review of management. Injury. 2001 Jun;32(5):363-372.
    [Google Scholar]
  5. , , , et al . Surgical management of complex proximal humerus fractures-a systematic review of 92 studies including 4500 patients. J Orthop Trauma. 2015 Jan;29(1):54-59.
    [Google Scholar]
  6. , , , . Management of acute proximal humeral fractures. J Am Acad Orthop Surg. 2017 Jan;25(1):42-52.
    [Google Scholar]
  7. , , , et al . Locking plate fixation of proximal humerus fractures in patients older than 60 years continues to be associated with a high complication rate. J Shoulder Elbow Surg. 2020 Aug;29(8):1689-1694.
    [Google Scholar]
  8. , , , , , . Reverse shoulder arthroplasty for proximal humeral fractures: outcomes comparing primary reverse arthroplasty for fracture versus reverse arthroplasty after failed osteosynthesis. J Shoulder Elbow Surg. 2016 Oct;25(10):1655-1660.
    [Google Scholar]
  9. , , , , , , . A comparison of pain, strength, range of motion, and functional outcomes after hemiarthroplasty and total shoulder arthroplasty in patients with osteoarthritis of the shoulder. A systematic review and meta-analysis. J Bone Joint Surg Am. 2005 Sep;87(9):1947-1956.
    [Google Scholar]
  10. , , , , , , . Primary hemiarthroplasty for treatment of proximal humeral fractures. J Bone Joint Surg Am. 2003 Jul;85(7):1215-1223.
    [Google Scholar]
  11. , , , , , , . Is reverse total shoulder arthroplasty more effective than hemiarthroplasty for treating displaced proximal humerus fractures in older adults? A systematic review and meta-analysis. Orthop Traumatol Surg Res. 2018 Oct;104(6):759-766.
    [Google Scholar]
  12. , , , et al . Are arthroplasty procedures really better in the treatment of complex proximal humerus fractures? A comprehensive meta-analysis and systematic review. J Orthop Trauma. 2021 Mar 1;35(3):111-119.
    [Google Scholar]
  13. , , , et al . Comparison of surgical and non-surgical treatments for 3- and 4-part proximal humerus fractures: a network meta-analysis. Shoulder Elbow. 2020 Apr;12(2):99-108.
    [Google Scholar]
  14. , , , , , . Nationwide trends in management of proximal humeral fractures: an analysis of 77,966 cases from 2008 to 2017. J Shoulder Elbow Surg. 2019 Nov;28(11):2072-2078.
    [Google Scholar]
  15. , , , et al . Comparison of surgical and non-surgical treatments for 3- and 4-part proximal humerus fractures: a network meta-analysis. Shoulder Elbow. 2020 Apr;12(2):99-108.
    [Google Scholar]
  16. , , , et al . Acute versus delayed reverse total shoulder arthroplasty for proximal humeral fractures: a consecutive cohort study. J Shoulder Elbow Surg. 2022 Feb;31(2):276-285.
    [Google Scholar]
  17. , , , et al . Reverse total shoulder arthroplasty for acute proximal humeral fracture: comparison to open reduction-internal fixation and hemiarthroplasty. J Shoulder Elbow Surg. 2014 Feb;23(2):197-204.
    [Google Scholar]
  18. Medicare Fee-For-Service Supplemental Improper Payment Data. 2020
    [Google Scholar]
  19. , , , et al . Trending a decade of proximal humerus fracture management in older adults. JSES Int. 2021 Oct 13;6(1):137-143.
    [Google Scholar]
  20. , , , et al . Reverse shoulder arthroplasty for recent proximal humerus fractures: outcomes in 422 cases. Orthop Traumatol Surg Res. 2019 Sep;105(5):805-811.
    [Google Scholar]
  21. , , , et al . Reverse shoulder arthroplasty for acute fractures in the elderly: is it worth reattaching the tuberosities? J Shoulder Elbow Surg. 2019 Mar;28(3):437-444.
    [Google Scholar]
  22. , , , , , . Trends in surgical management and costs for operative treatment of proximal humerus fractures in the elderly. Orthopedics. 2017 Jul 1;40(4):e641-e647.
    [Google Scholar]
  23. , , , et al . Trends in epidemiology and patho-anatomical pattern of proximal humeral fractures. Int Orthop. 2014 Aug;38(8):1697-1704.
    [Google Scholar]
  24. , , , et al . Epidemiology of proximal humerus fractures. J Orthop Surg Res. 2021 Jun 22;16(1):402.
    [Google Scholar]
  25. , , , , . Outcomes of acute versus delayed reverse shoulder arthroplasty for proximal humerus fractures in the elderly: a systematic review and meta-analysis. J Shoulder Elbow Surg 2023 Apr 5
    [Google Scholar]
  26. , , , , , . Acute versus delayed reverse total shoulder arthroplasty for the treatment of proximal humeral fractures in the elderly population: a systematic review and meta-analysis. J Shoulder Elbow Surg. 2019 Apr;28(4):765-773.
    [Google Scholar]
  27. , , , , , . Primary versus salvage reverse total shoulder arthroplasty for displaced proximal humerus fractures in the elderly: a systematic review and meta-analysis. J Shoulder Elb Arthroplast. 2020 Sep 15;4
    [Google Scholar]
  28. , , , et al . Clinical outcomes of reverse total shoulder arthroplasty for elective indications versus acute 3- and 4-part proximal humeral fractures: a systematic review and meta-analysis. J Shoulder Elbow Surg. 2022 Jan;31(1):e14-e21.
    [Google Scholar]
  29. , , , . Hospital readmissions after primary shoulder arthroplasty. J Shoulder Elbow Surg. 2014 Sep;23(9):1349-1355.
    [Google Scholar]
  30. , , , et al . Preoperative parameters that predict postoperative patient-reported outcome measures and range of motion with anatomic and reverse total shoulder arthroplasty. JSES Open Access. 2019 Nov 18;3(4):266-272.
    [Google Scholar]
  31. , , , , , , . Evidence-based algorithm to treat patients with proximal humerus fractures-a prospective study with early clinical and overall performance results. J Shoulder Elbow Surg. 2019 Jun;28(6):1022-1032.
    [Google Scholar]
  32. , , , , , . Interventions for Treating 3- or 4-part proximal humeral fractures in elderly patient: a network meta-analysis of randomized controlled trials. Int J Surg. 2017 Dec;48:240-246.
    [Google Scholar]
  33. , , , , , , . Reverse shoulder arthroplasty versus nonoperative treatment for 3- or 4-part proximal humeral fractures in elderly patients: a prospective randomized controlled trial. J Shoulder Elbow Surg. 2019 Dec;28(12):2259-2271.
    [Google Scholar]
Show Sections